Developer docs
API playgroundTry for free, no card

Search company profiles

O.G. Venture Partners

Full company profile

uuid00009sz

Namestring
O.G. Venture Partners
Legal namestring
O.G. Venture Partners
Websiteurl
og-vp.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

O.G. Venture Partners is a multi-stage venture capital firm founded in 2017 that invests primarily in B and C rounds of early-growth technology companies. The firm concentrates on AI-enabled businesses across multiple verticals, including financial crime detection and RegTech (IVIX), preventive healthcare technology (Neko Health), public safety and government data integration (Peregrine Technologies), and AI platforms for residential real estate (Breezy). It is led by founder Eyal Ofer alongside managing partners Roy Oron and Ziv Kop, operates with a lean team of 1-10 employees, and maintains an online presence through og-vp.com.

The firm's documented investment activity spans 2025 and 2026, including a $60M Series B led by O.G. Venture Partners for IVIX, participation in Neko Health's $260M Series B alongside Lightspeed Venture Partners, General Catalyst, Lakestar, and Atomico, a $10M pre-seed in Breezy with Ribbit Capital, Fifth Wall, DST Global Partners, and Liquid 2 Ventures, and a participation in Peregrine Technologies' $250M Series D at a $6.8B valuation. Portfolio companies operate globally, including in the U.S., U.K., Sweden, and Canada, indicating cross-border deal sourcing and value creation support. The firm consistently co-invests alongside top-tier VCs including Sequoia Capital, Lightspeed Venture Partners, Ribbit Capital, and General Catalyst, which suggests access to competitive deal flow and allocation in sought-after rounds.

As a venture capital firm, O.G. Venture Partners generates revenue through management fees on assets under management and carried interest on successful exits. The firm's AUM, fund vintages, LP composition, and fee structures are not publicly disclosed. Geographic reach is global based on portfolio composition, and the firm's strategy is characterized by a horizontal AI thesis applied across vertical-specific regulated and high-value markets.

Short descriptiontext

O.G. Venture Partners is a multi-stage venture capital firm founded in 2017 that invests in AI-enabled technology companies across RegTech, HealthTech, GovTech, and PropTech at B and C rounds.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMonaco, Germany
HQ citystring
Monaco
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
venture capital funding, growth stage investing, technology startup investment, multi-stage VC firm, private equity investments
Industry3 codes
1Early-Stage Venture Capital (Series A/B)
CodeFSANAAABPrimaryYes
2Late-Stage Venture Capital (Series C+)
CodeFSANAAACPrimaryNo
3Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryNo
NAICS code1 code
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

O.G. Venture Partners is a multi-stage venture capital firm that invests growth capital into early-growth and growth-stage technology companies, typically participating at Series B and Series C rounds with selective pre-seed and Series D involvement. The firm deploys capital across AI, GovTech, HealthTech, PropTech, and financial crime/compliance technology sectors, leading or co-investing alongside tier-one VCs such as Lightspeed Venture Partners, Ribbit Capital, General Catalyst, Sequoia Capital, Lakestar, and Atomico. Its fundamental product is fund-based equity investment into portfolio companies in exchange for ownership stakes and the prospect of investment returns.

Differentiator
Functional benefit
Problem solved
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pre-seed and seed-stage VC co-investing in Breezy. Liquid 2's early-stage focus is comparable to O.G. Venture Partners' pre-seed participation in Breezy, reflecting similar positioning at the front end of the venture funnel.

TypeDirect peer
Description

Multi-stage global VC firm that co-invested with O.G. Venture Partners in Neko Health's $260M Series B. Both firms pursue early-to-growth technology opportunities across similar geographies and stages, making Lightspeed a direct comparable in fund mandate.

TypeDirect peer
Description

European multi-stage VC co-investing in Neko Health. Lakestar's pan-European orientation and stage focus align with O.G. Venture Partners' EMEA-linked activity (Monaco/Germany domicile, Neko Health in Sweden).

TypeDirect peer
Description

European-rooted multi-stage VC co-investing in Neko Health's Series B. Atomico operates at similar stages and geographies to O.G. Venture Partners, with comparable fund-size profile and cross-border investment approach.

TypeDirect peer
Description

Fintech-focused VC that co-invested in Breezy's pre-seed round alongside O.G. Venture Partners. Ribbit's sector specialization in financial services and AI in financial crime overlaps with O.G. Venture Partners' IVIX thesis.

TypeDirect peer
Description

PropTech-focused VC co-investing in Breezy's pre-seed. Fifth Wall is a direct comparable in the PropTech vertical where O.G. Venture Partners has placed a thesis bet via the Breezy investment.

TypeOthers
Description

While not a direct competitor, Atomico's broader network of syndicate angels and partner programs serves a comparable founder audience and overlaps in deal flow that O.G. Venture Partners taps into through co-investment relationships.

TypeDirect peer
Description

Multi-stage VC firm co-investing in Neko Health's Series B. General Catalyst shares O.G. Venture Partners' orientation toward high-conviction, thesis-driven growth investing and overlapping sector coverage in AI and regulated industries.

TypeBroad incumbent
Description

Premier global venture firm operating across stages and geographies. Although significantly larger, Sequoia is referenced as a co-investor in the firm's deal flow and serves as the upper-bound benchmark for early-to-growth-stage VC strategy.

TypeDirect peer
Description

Late-stage global investor co-investing in Breezy's pre-seed. DST shares O.G. Venture Partners' multi-stage, multi-geography approach with similar fund-size tier and willingness to participate across stages.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment53 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

O.G. Venture Partners

Venture Capitalog-vp.com

O.G. Venture Partners is a multi-stage venture capital firm founded in 2017 that invests in AI-enabled technology companies across RegTech, HealthTech, GovTech, and PropTech at B and C rounds.

What O.G. Venture Partners does

O.G. Venture Partners is a multi-stage venture capital firm founded in 2017 that invests primarily in B and C rounds of early-growth technology companies. The firm concentrates on AI-enabled businesses across multiple verticals, including financial crime detection and RegTech (IVIX), preventive healthcare technology (Neko Health), public safety and government data integration (Peregrine Technologies), and AI platforms for residential real estate (Breezy). It is led by founder Eyal Ofer alongside managing partners Roy Oron and Ziv Kop, operates with a lean team of 1-10 employees, and maintains an online presence through og-vp.com.

The firm's documented investment activity spans 2025 and 2026, including a $60M Series B led by O.G. Venture Partners for IVIX, participation in Neko Health's $260M Series B alongside Lightspeed Venture Partners, General Catalyst, Lakestar, and Atomico, a $10M pre-seed in Breezy with Ribbit Capital, Fifth Wall, DST Global Partners, and Liquid 2 Ventures, and a participation in Peregrine Technologies' $250M Series D at a $6.8B valuation. Portfolio companies operate globally, including in the U.S., U.K., Sweden, and Canada, indicating cross-border deal sourcing and value creation support. The firm consistently co-invests alongside top-tier VCs including Sequoia Capital, Lightspeed Venture Partners, Ribbit Capital, and General Catalyst, which suggests access to competitive deal flow and allocation in sought-after rounds.

As a venture capital firm, O.G. Venture Partners generates revenue through management fees on assets under management and carried interest on successful exits. The firm's AUM, fund vintages, LP composition, and fee structures are not publicly disclosed. Geographic reach is global based on portfolio composition, and the firm's strategy is characterized by a horizontal AI thesis applied across vertical-specific regulated and high-value markets.

O.G. Venture Partners firmographics

Firmographics
Name
O.G. Venture Partners
Legal name
O.G. Venture Partners
Website
https://og-vp.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
O.G. Venture Partners is a multi-stage venture capital firm founded in 2017 that invests in AI-enabled technology companies across RegTech, HealthTech, GovTech, and PropTech at B and C rounds.
Ownership category
akta.pro rank

O.G. Venture Partners industry classification

Industry
Product category
Venture Capital
NAICS
All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro primary industry
Early-Stage Venture Capital (Series A/B) (FSANAAAB)
akta.pro secondary industries
Late-Stage Venture Capital (Series C+) (FSANAAAC), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital funding
  • Growth stage investing
  • Technology startup investment
  • Multi-stage VC firm
  • Private equity investments

Where O.G. Venture Partners is headquartered

Location

Headquarters

HQ city
Monaco
HQ country
Germany
HQ region
Europe

Markets served

O.G. Venture Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

O.G. Venture Partners product offering

Product offering

Core offering

O.G. Venture Partners is a multi-stage venture capital firm that invests growth capital into early-growth and growth-stage technology companies, typically participating at Series B and Series C rounds with selective pre-seed and Series D involvement. The firm deploys capital across AI, GovTech, HealthTech, PropTech, and financial crime/compliance technology sectors, leading or co-investing alongside tier-one VCs such as Lightspeed Venture Partners, Ribbit Capital, General Catalyst, Sequoia Capital, Lakestar, and Atomico. Its fundamental product is fund-based equity investment into portfolio companies in exchange for ownership stakes and the prospect of investment returns.

Differentiator

Problem solved

Functional benefit

Companies that use O.G. Venture Partners

Customer profile

Segments4 records

Ideal customer profiles4 records

O.G. Venture Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

O.G. Venture Partners partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

O.G. Venture Partners competitors and assessment

Company assessment

Direct peers

  • Liquid 2 Ventures: Pre-seed and seed-stage VC co-investing in Breezy. Liquid 2's early-stage focus is comparable to O.G. Venture Partners' pre-seed participation in Breezy, reflecting similar positioning at the front end of the venture funnel.
  • Lightspeed Venture Partners: Multi-stage global VC firm that co-invested with O.G. Venture Partners in Neko Health's $260M Series B. Both firms pursue early-to-growth technology opportunities across similar geographies and stages, making Lightspeed a direct comparable in fund mandate.
  • Lakestar: European multi-stage VC co-investing in Neko Health. Lakestar's pan-European orientation and stage focus align with O.G. Venture Partners' EMEA-linked activity (Monaco/Germany domicile, Neko Health in Sweden).
  • Atomico: European-rooted multi-stage VC co-investing in Neko Health's Series B. Atomico operates at similar stages and geographies to O.G. Venture Partners, with comparable fund-size profile and cross-border investment approach.
  • Ribbit Capital: Fintech-focused VC that co-invested in Breezy's pre-seed round alongside O.G. Venture Partners. Ribbit's sector specialization in financial services and AI in financial crime overlaps with O.G. Venture Partners' IVIX thesis.
  • Fifth Wall: PropTech-focused VC co-investing in Breezy's pre-seed. Fifth Wall is a direct comparable in the PropTech vertical where O.G. Venture Partners has placed a thesis bet via the Breezy investment.
  • General Catalyst: Multi-stage VC firm co-investing in Neko Health's Series B. General Catalyst shares O.G. Venture Partners' orientation toward high-conviction, thesis-driven growth investing and overlapping sector coverage in AI and regulated industries.
  • DST Global Partners: Late-stage global investor co-investing in Breezy's pre-seed. DST shares O.G. Venture Partners' multi-stage, multi-geography approach with similar fund-size tier and willingness to participate across stages.

Others

  • Atomico Angels: While not a direct competitor, Atomico's broader network of syndicate angels and partner programs serves a comparable founder audience and overlaps in deal flow that O.G. Venture Partners taps into through co-investment relationships.

Broad incumbents

  • Sequoia Capital: Premier global venture firm operating across stages and geographies. Although significantly larger, Sequoia is referenced as a co-investor in the firm's deal flow and serves as the upper-bound benchmark for early-to-growth-stage VC strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

O.G. Venture Partners social profiles

Digital presence

O.G. Venture Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

O.G. Venture Partners leadership team

Management profile

Number of profiles

Profiles3 records

O.G. Venture Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

O.G. Venture Partners M&A and investment

M&A and investment

M&A1 record

Investments53 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about O.G. Venture Partners

What does O.G. Venture Partners do?

O.G. Venture Partners is a multi-stage venture capital firm that invests growth capital into early-growth and growth-stage technology companies, typically participating at Series B and Series C rounds with selective pre-seed and Series D involvement. The firm deploys capital across AI, GovTech, HealthTech, PropTech, and financial crime/compliance technology sectors, leading or co-investing alongside tier-one VCs such as Lightspeed Venture Partners, Ribbit Capital, General Catalyst, Sequoia Capital, Lakestar, and Atomico. Its fundamental product is fund-based equity investment into portfolio companies in exchange for ownership stakes and the prospect of investment returns.

Is O.G. Venture Partners a public or private company?

O.G. Venture Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was O.G. Venture Partners founded?

O.G. Venture Partners was founded in 2017. It employs 1 to 10 people.

Where is O.G. Venture Partners based?

O.G. Venture Partners is headquartered in Monaco, Germany, in the Europe region.

Who are O.G. Venture Partners's main competitors?

Direct peers on record are Liquid 2 Ventures, Lightspeed Venture Partners, Lakestar, Atomico, Ribbit Capital, Fifth Wall, General Catalyst and DST Global Partners. Atomico Angels is listed as an others. Sequoia Capital is listed as a broad incumbent.

Does O.G. Venture Partners have an API?

No public API is recorded for O.G. Venture Partners.

What industry is O.G. Venture Partners in?

O.G. Venture Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAC, Late-Stage Venture Capital (Series C+). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SourceryICYMI: Neko Health Opens in NYCNeko Health opened its first NYC clinic, with over 30,000 New Yorkers on the waitlist. Its $499 scan takes about 60 minutes and returns results on-site. The company plans additional NYC locations and expansion to Miami, D.C., and San Francisco.PR NewswireNEKO HEALTH OPENS ITS DOORS IN NEW YORK, BRINGING THE MOST VALUABLE HOUR IN HEALTHCARE TO AMERICANeko Health opened its first U.S. clinic in SoHo, New York, on Sept. 24, 2026, after over 25,000 New Yorkers joined the waitlist. The 60-minute scan costs $499 and combines skin, cardiovascular, and blood testing with clinician review. Additional New York locations and a Miami clinic are planned.SiliconANGLEBuildots raises $130 million to expand AI-powered construction platformBuildots raised $130 million in late-stage funding, bringing total capital to $297 million. The Tel Aviv-based construction management startup uses AI and computer vision to track project progress. It plans to expand across North America and Europe and extend its software to more construction stages.Pulse 2.0Buildots Raises $130 Million To Scale AI Construction Platform And Support Global Data Center BuildoutBuildots raised $130 million in a funding round led by O.G. Venture Partners to expand its AI construction platform. The round brings total capital to $297 million, with over 100 large organizations using the platform, including Digital Realty and Intel. The company plans to broaden adoption across North America and EMEA and expand technology across construction lifecycle stages.Investing.comBuildots shares funding round details as AI demand lifts construction By Investing.comBuildots raised $130 million in a funding round led by O.G. Venture Partners, bringing total capital to $297 million. The Tel Aviv-based AI construction platform, used by over 100 firms, will use the funds to scale deployments and expand into North America and EMEA.FinSMEsBuildots Raises $130M in FundingBuildots, an AI-powered construction intelligence platform, raised $130M in funding led by O.G. Venture Partners, bringing total funding to $297M. The company will use the funds to expand into more construction portfolios across North America and EMEA and enhance its platform capabilities.PR NewswireBuildots raises $130M to bring AI to the $16T construction industry - and power the global data center buildoutBuildots announced a $130M funding round led by O.G. Venture Partners, bringing total funds to $297M. The company's AI platform serves over 100 large construction firms, including Intel and Digital Realty. The round adds Human Capital and Mohari Ventures to its cap table.The Pharma LetterRemepy raises $36m to take hybrid Parkinson's drug into Phase IIIRemepy closed a $36 million Series A round to fund global Phase III testing of its Parkinson's drug Hybridopa. The round, co-led by O.G. Venture Partners and M Ventures, brings total capital to $62 million. The financing also supports expanding its model pairing prescription medicines with AI-driven therapeutic software.Venture Capital Access OnlineRemepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's DiseaseRemepy closed a $36 million Series A led by O.G. Venture Partners and M Ventures, bringing total funding to $62 million. The proceeds will fund Phase III clinical development of Hybridopa for Parkinson's disease, expected to commence in Q4 2026, and expand its Hybrid Drug pipeline.PR NewswireRemepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's DiseaseRemepy closed a $36 million Series A led by O.G. Venture Partners and M Ventures, bringing total capital to $62 million. The funds will accelerate co-development partnerships and global Phase III of Hybridopa for Parkinson's disease, expected to commence in Q4 2026.